SG11202012005VA - Fluticasone furoate nasal preparation composition - Google Patents

Fluticasone furoate nasal preparation composition

Info

Publication number
SG11202012005VA
SG11202012005VA SG11202012005VA SG11202012005VA SG11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA
Authority
SG
Singapore
Prior art keywords
preparation composition
fluticasone furoate
nasal preparation
furoate nasal
fluticasone
Prior art date
Application number
SG11202012005VA
Other languages
English (en)
Inventor
Taizou Kamishita
Takashi Miyazaki
Original Assignee
Toko Yakuhin Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toko Yakuhin Kogyo Co Ltd filed Critical Toko Yakuhin Kogyo Co Ltd
Publication of SG11202012005VA publication Critical patent/SG11202012005VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202012005VA 2018-06-08 2019-06-07 Fluticasone furoate nasal preparation composition SG11202012005VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018110634 2018-06-08
PCT/JP2019/022743 WO2019235616A1 (fr) 2018-06-08 2019-06-07 Composition de préparation nasale de furoate de fluticasone

Publications (1)

Publication Number Publication Date
SG11202012005VA true SG11202012005VA (en) 2021-01-28

Family

ID=68770324

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012005VA SG11202012005VA (en) 2018-06-08 2019-06-07 Fluticasone furoate nasal preparation composition

Country Status (11)

Country Link
US (1) US12102645B2 (fr)
EP (1) EP3804729A4 (fr)
JP (1) JPWO2019235616A1 (fr)
KR (1) KR102915126B1 (fr)
CN (1) CN112423763A (fr)
AU (1) AU2019283247B2 (fr)
BR (1) BR112020023444A2 (fr)
CA (1) CA3100679A1 (fr)
SG (1) SG11202012005VA (fr)
TW (1) TWI859143B (fr)
WO (1) WO2019235616A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022006028A2 (fr) * 2020-06-29 2022-01-06 Anovent Pharmaceutical (Us), Llc Formulation pharmaceutique contenant une combinaison d'un agoniste bêta-2 antagoniste de m3 et de corticostéroïdes inhalés

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1210357A (en) 1966-12-09 1970-10-28 Owen Hayden Thermal insulation structures
EP0709099A3 (fr) 1994-09-28 1996-07-24 Senju Pharma Co Suspension aqueuse nasale comprenant cyclodextrine
US7074388B2 (en) 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
SI1775305T1 (sl) 2000-08-05 2015-01-30 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
JP2006069946A (ja) * 2004-09-01 2006-03-16 Aska Pharmaceutical Co Ltd 微量定量噴霧用の水性懸濁剤
US8136703B2 (en) 2006-04-21 2012-03-20 Toko Yakuhin Kogyo Kabushiki Kaisha Fluid container and airless fluid dispensing system
DK2014305T3 (en) * 2006-04-21 2017-10-16 Toko Yakuhin Kogyo Kk SPRAYABLE GEL-SHAPED SKIN / MOSPHONE ADHESIVE AND ADMINISTRATIVE SYSTEM FOR USING THE PREPARATION
CN101474192A (zh) * 2009-01-20 2009-07-08 崔晓廷 糠酸氟替卡松药物制剂及制备方法
WO2012094283A2 (fr) 2011-01-04 2012-07-12 Ista Pharmaceuticals, Inc. Compositions de bépostatine
RU2652352C2 (ru) 2012-12-17 2018-04-25 Глаксо Груп Лимитед Комбинация левокабастина и флутиказона фуроата для лечения воспалительных и/или аллергических состояний

Also Published As

Publication number Publication date
AU2019283247B2 (en) 2025-03-27
JPWO2019235616A1 (ja) 2021-06-17
KR102915126B1 (ko) 2026-01-20
CA3100679A1 (fr) 2019-12-12
KR20210020068A (ko) 2021-02-23
BR112020023444A2 (pt) 2021-02-23
TWI859143B (zh) 2024-10-21
US20210236515A1 (en) 2021-08-05
AU2019283247A1 (en) 2020-12-24
TW202015700A (zh) 2020-05-01
EP3804729A1 (fr) 2021-04-14
WO2019235616A1 (fr) 2019-12-12
EP3804729A4 (fr) 2022-03-09
US12102645B2 (en) 2024-10-01
CN112423763A (zh) 2021-02-26

Similar Documents

Publication Publication Date Title
ZA201906613B (en) Pharmaceutical compositions for combination therapy
IL261924A (en) Steroid hormone pharmaceutical composition
ZA201806414B (en) Steroid hormone pharmaceutical composition
ZA201905510B (en) Pharmaceutical compositions for combination therapy
GB201911517D0 (en) Pharmaceutical composition
GB201807053D0 (en) Pharmaceutical composition
GB201804548D0 (en) Pharmaceutical compositions
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
HUE064916T2 (hu) Gyógyászati készítmény
PL3823655T3 (pl) Kompozycje do leczenia wulwodynii
PL3606505T3 (pl) Kompozycja do podawania donosowego
GB201808571D0 (en) Pharmaceutical compositions
GB201808567D0 (en) Pharmaceutical compositions
IL285728A (en) Pharmaceutical composition
EP3593801A4 (fr) Composition d'émulsion acide contenant un agent anesthésique local
SG11202012005VA (en) Fluticasone furoate nasal preparation composition
PL3949952T3 (pl) Kompozycja farmaceutyczna
SG11202103374TA (en) Pharmaceutical composition
PT3650024T (pt) Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência
ZA202103782B (en) Teriflunomide topical pharmaceutical compositions
SG11202103851PA (en) Dry pharmaceutical composition for inhalation
GB201912686D0 (en) Pharmaceutical composition
PT3893845T (pt) Composição compreendendo dutasterida
GB201820689D0 (en) Pharmaceutical composition
GB201908003D0 (en) Pharmaceutical composition